Financial Publications

08.05.2025

Gilching (pta012/08.05.2025/08:30) - * Hönle Group increases revenue from €21.4 million in the first quarter to €25.8 million in the second quarter * Discontinuation of unprofitable product lines and initiated cost-cutting measures are showing results * EBITDA increases from €2.6...

25.02.2025

Gilching (pta008/25.02.2025/08:45) - * Q1 sales of €21.4 million below previous year's figure of €23.8 million due to structural and economic effects * Cost-cutting measures introduced are showing initial positive effects * EBITDA increases from €0.6 million to €1.0 million *...

17.02.2025

Gilching (pta019/17.02.2025/12:55) - Release of Voting Rights Announcement

12.02.2025

Gilching (pta026/12.02.2025/13:00) - Release of Voting Rights Announcement

12.02.2025

Gilching (pta028/12.02.2025/13:00) - Release of Voting Rights Announcement

06.02.2025

Gilching (pta011/06.02.2025/10:21) - Dr. Hönle AG announces that the following financial reports shall be disclosed:

02.01.2025

Gilching (pta018/02.01.2025/11:30) - Release of Voting Rights Announcement

02.01.2025

Gilching (pta020/02.01.2025/11:30) - Release of Voting Rights Announcement

06.12.2024

Gilching (pta008/06.12.2024/08:40) - According to preliminary and unaudited figures, the Hönle Group achieved the following results in the 2023/24 financial year:

20.11.2024

Gilching (pta024/20.11.2024/16:50) - Dr. Hönle AG announces that the following financial reports shall be disclosed:

07.08.2024

Gilching (pta022/07.08.2024/16:10) - Release of Voting Rights Announcement

07.08.2024

Gilching (pta020/07.08.2024/16:05) - Release of Voting Rights Announcement

07.08.2024

Gilching (pta006/07.08.2024/08:40) - - Sales of €72.1 million are 9.6% below the previous year's figures

06.08.2024

Gilching (pta021/06.08.2024/11:25) - On 2 August 2024, the Supervisory Board of Dr. Hönle AG appointed Robert Stark as a member of the Management Board of Dr. Hönle AG effective 1 October 2024. Robert Stark will assume the post of Chief Financial Officer. Dr. Markus Arendt was appointed...

08.05.2024

Gilching (pta009/08.05.2024/08:10) - * Weakness in machinery and plant engineering and project postponements in the solar industry and electromobility business lead to a 10.1% decline in sales to € 48.1 million * Operating result is € –0.1 million after € 3.7 million in the...

07.05.2024

Gilching (pta010/07.05.2024/08:55) - As planned, Dr. Markus Arendt took up his position as CEO of Dr. Hönle AG on May 1, 2024. He succeeds Dr. Franz Richter, who was appointed to the Executive Board by the Supervisory Board for a year. Franz Richter returns to the Supervisory Board and...

18.04.2024

Gilching (pta028/18.04.2024/15:30) - Dr. Hönle AG announces that the following financial reports shall be disclosed:

27.02.2024

Gilching (pta019/27.02.2024/10:45) - Release of Voting Rights Announcement

26.02.2024

Gilching (pta006/26.02.2024/07:55) - * Revenue in the first quarter of €23.8 million below the previous year's figure of €27.6 million due to the weak market environment * Operating result of € -0.8 million after € 1.9 million in the previous year * Positive operating cash flow of...

23.02.2024

Gilching (pta025/23.02.2024/14:19) - Release of Voting Rights Announcement

23.02.2024

Gilching (pta019/23.02.2024/12:49) - Release of Voting Rights Announcement

22.02.2024

Gilching (pta023/22.02.2024/13:00) - Announcement

22.02.2024

Gilching (pta025/22.02.2024/13:00) - Announcement

22.02.2024

Gilching (pta027/22.02.2024/13:00) - Announcement

15.02.2024

Gilching (pta028/15.02.2024/15:55) - Release of Voting Rights Announcement

07.12.2023

Gilching (pta036/07.12.2023/17:50) - According to preliminary figures, the Hönle Group achieved sales of €106.3 million in the 2022/2023 financial year (previous year: €116.1 million from continuing operations). Sales are therefore above the previously communicated target range of...

03.11.2023

Gilching (pta015/03.11.2023/11:45) - Dr. Hönle AG announces that the following financial reports shall be disclosed:

20.10.2023

Gilching (pta026/20.10.2023/18:30) - The Supervisory Board of Dr. Hönle AG intends to appoint Dr. Markus Arendt as a member of the Management Board of Dr. Hönle AG with effect presumably from May 1st, 2024. He will follow Dr. Franz Richter, who was delegated to the Management Board by...

07.08.2023

Gilching (pta011/07.08.2023/08:30) - * Still high order backlog * Revenue decreases by 8.5% to €79.7 million due to a drop in revenue in the air sterilization sector * Discontinuation of the product line of mobile air disinfection systems and the resignation of a member of the...

30.06.2023

Gilching (pta013/30.06.2023/09:20) - Release of Voting Rights Announcement

12.06.2023

Gilching (pta025/12.06.2023/11:20) - Announcement

07.06.2023

Gilching (pta052/07.06.2023/17:30) - Announcement

07.06.2023

Gilching (pta050/07.06.2023/17:25) - Announcement

07.06.2023

Gilching (pta048/07.06.2023/17:20) - Announcement

07.06.2023

Gilching (pta036/07.06.2023/17:10) - Announcement

07.06.2023

Gilching (pta034/07.06.2023/16:45) - Release of Voting Rights Announcement

12.05.2023

Gilching (pta009/12.05.2023/08:20) - At T€ 53,520 sales revenues generated by the Hönle Group in the first six months of financial year 2022/2023 were below the prior year's figure of T€ 60,807. The decline is mainly due to the air disinfection business, in which sales decreased by...

25.04.2023

Gilching (pta046/25.04.2023/23:40) - The Supervisory Board of Dr. Hönle AG delegates Dr. Franz Richter, who currently holds the position of Chairman of the Supervisory Board of Dr. Hönle AG, as the successor to the Chairman of the Management Board, Mr. Norbert Haimerl, who is resigning...

31.03.2023

Gilching (pta022/31.03.2023/09:55) - The Annual General Meeting has elected Dr. Franz Richter to the Supervisory Board of Dr. Hönle AG. Dr. Richter takes over the chairmanship of the supervisory board and thus succeeds Prof. Dr. Karl Hönle, who resigned from office with effect from the...

15.02.2023

Gilching (pta019/15.02.2023/12:15) - Announcement

17.01.2023

Gilching (pta010/17.01.2023/09:35) - Release of Voting Rights Announcement

15.12.2022

Gilching (pta026/15.12.2022/14:00) - Prof. Dr. Karl Hönle, company founder and long-time chairman of the supervisory board of Dr. Hönle AG will resign from office at the next Annual General Meeting on March 23, 2023 and will be leaving the Supervisory Board at his own request. The...

09.12.2022

Gilching (pta022/09.12.2022/15:24) - Release of Voting Rights Announcement

19.10.2022

Gilching (pta021/19.10.2022/14:02) - Dr. Hönle AG announces that the following financial reports shall be disclosed:

02.09.2022

Gilching (pta024/02.09.2022/12:00) - Release of Voting Rights Announcement

02.09.2022

Gilching (pta019/02.09.2022/11:05) - Announcement

05.08.2022

Gilching (pta009/05.08.2022/08:00) - Sales revenues generated by the Hönle Group rose by 12% to T€ 95,141 in the first nine months of financial year 2021/2022 compared with the prior-year period.

16.05.2022

Gilching (pta026/16.05.2022/11:45) - The supervisory board of Dr. Hönle AG has decided to restructure the Management Board of Dr. Hönle AG.

12.05.2022

Gilching (pta006/12.05.2022/08:00) - The economic recovery impacted positively on the Hönle Group's course of business. Both incoming orders and order backlog were clearly above the prior year's level. An even higher rise in revenue failed to realise due to long delivery times concerning...

11.05.2022

Gilching (pta043/11.05.2022/19:30) - Dr. Hönle AG announces that the following financial reports shall be disclosed:

31.03.2022

Gilching (pta104/31.03.2022/15:35) - Announcement

23.03.2022

Gilching (pta031/23.03.2022/14:30) - Release of Voting Rights Announcement

28.02.2022

Gilching (pta043/28.02.2022/15:30) - Release of Voting Rights Announcement

28.02.2022

Gilching (pta033/28.02.2022/14:40) - Release of Voting Rights Announcement

24.02.2022

Gilching (pta015/24.02.2022/12:00) - Release of Voting Rights Announcement

22.02.2022

Gilching (pta025/22.02.2022/11:00) - In the first quarter of financial year 2021/2022, the Hönle Group's revenues rose by 25.3% to T€ 33,418 compared to the prior year quarter. Both the Equipment & Systems and Glass & Lamps segments recorded significant revenue increases. A...

26.10.2021

Gilching (pta013/26.10.2021/11:15) - Announcement

06.08.2021

Gräfelfing/München (pta007/06.08.2021/08:05) - Revenues earned by the Hönle Group in the 9-month period climbed from T€ 71,734 in the previous year to T€ 84,932 in the current financial year. The following factors led to a slowdown in the Hönle Group's business development in the...

01.07.2021

Graefelfing, Munich (pta031/01.07.2021/15:00) - Announcement

12.05.2021

Gräfelfing/München (pta011/12.05.2021/08:05) - Although the Hönle Group was still largely spared from the corona pandemic in the first half of the previous year, the reluctance to invest especially in the printing business was clearly felt in the current financial year. Nevertheless,...

22.02.2021

Gräfelfing, Munich (pta011/22.02.2021/08:00) - In particular, as a consequence of acquisitions, the Hönle Group's sales revenues increased by 4.6% to TEur 26,673 in the first quarter of financial year 2020/2021. With Sterilsystems GmbH, based in Austria, Hönle acquired a company...

12.02.2021

Graefelfing, Munich (pta014/12.02.2021/10:45) - Dr. Hönle AG announces that the following financial reports shall be disclosed:

02.12.2020

Gräfelfing/München (pta009/02.12.2020/07:40) - From spring 2020, the business development of the Hönle Group was increasingly influenced by the effects of the global corona pandemic. According to preliminary figures, sales in the 2019/2020 financial year were therefore Eur 93.9 million...

01.09.2020

Graefelfing, Munich (pta027/01.09.2020/15:05) - Publication

18.08.2020

Gräfelfing/München (pta030/18.08.2020/16:05) - Dr. Hönle AG acquires STERILSYSTEMS GmbH. The Hönle Group is thus significantly expanding its activities in the life science sector. As a result of the pandemic, sensitivity to and global demand for disinfection solutions has risen...

07.08.2020

Graefelfing (pta013/07.08.2020/07:40) - The Hönle Group generated sales revenues of TEur 71.734 in the first nine months of the financial year 2019/2020, which is 11.7% below the previous year's level. The operating result (EBIT) dropped from TEur 13,256 to TEur 6,287. The COVID 19...

15.05.2020

Gräfelfing/München (pta008/15.05.2020/08:00) - The Hönle Group's sales in the first six months of the 2019/2020 financial year were Eur 50,853 thousand, 9.2% below the previous year's figure. The operating result fell by 43.2% to Eur 5,786 thousand. As in the previous year, a lower...

30.03.2020

Graefelfing, Munich (pta009/30.03.2020/09:20) - Announcement

06.03.2020

Graefelfing,Munich (pta017/06.03.2020/10:35) - Release of Voting Rights Announcement

26.02.2020

Graefelfing, Munich (pta026/26.02.2020/17:50) - Announcement

21.02.2020

Gräfelfing/München (pta007/21.02.2020/08:00) - Revenue earned by the Hönle Group declined from TEur 30,250 in the previous year to TEur 25,499 in the first quarter of financial year 2019/2020. In the previous year already, a significantly lower order volume with a major customer in the...

07.02.2020

Graefelfing (pta016/07.02.2020/11:43) - Release of Voting Rights Announcement

09.01.2020

Graefelfing, Munich (pta023/09.01.2020/17:38) - Dr. Hönle AG announces that the following financial reports shall be disclosed:

19.11.2019

Gräfelfing, Munich (pta042/19.11.2019/18:40) - Release of Voting Rights Announcement

07.11.2019

Gräfelfing/München (pta021/07.11.2019/10:45) - Release of Voting Rights Announcement

24.10.2019

Graefelfing, Munich (pta031/24.10.2019/18:30) - Release of Voting Rights Announcement

22.10.2019

Graefelfing, Munich (pta012/22.10.2019/09:45) - Release of Voting Rights Announcement

16.09.2019

Graefelfing, Munich (pta039/16.09.2019/17:30) - Release of Voting Rights Announcement

28.08.2019

Gräfelfing (pta033/28.08.2019/13:30) - Release of Voting Rights Announcement

09.08.2019

Gräfelfing/München (pta010/09.08.2019/08:30) - The Hönle Group's sales revenues came to TEur 81,240 in the nine-month period, which is 8.5% below the previous year's figure. The operating result (EBIT) decreased from TEur 19,865 to TEur 13,256, which translates into an EBIT margin of...

02.08.2019

Graefelfing, Munich (pta021/02.08.2019/11:30) - Release of Voting Rights Announcement

05.07.2019

Graefelfing (pta022/05.07.2019/13:50) - Release of Voting Rights Announcement

25.06.2019

Graefelfing, Munich (pta026/25.06.2019/14:00) - Release of Voting Rights Announcement

12.06.2019

Graefelfing, Munich (pta028/12.06.2019/14:25) - Release of Voting Rights Announcement

17.05.2019

Gräfelfing/München (pta009/17.05.2019/08:00) - The Hönle Group's sales revenues decreased by 7.7 % to TEur 55,990 in the first six months of the 2018/2019 financial year compared with the prior-year period. Owing to lower adhesives sales, the operating result (EBIT) decreased from TEur...

22.02.2019

Graefelfing, Munich (pta011/22.02.2019/07:35) - Revenues of the Hönle Group in the first quarter of Eur 30,250 thousand were 2.4% higher than in the same period of the previous year. The operating result (EBIT) amounted to Eur 6,555 thousand (previous year: Eur 7,392 thousand). This...

11.02.2019

Graefelfing, Munich (pta010/11.02.2019/10:33) - Release of Voting Rights Announcement

25.01.2019

Graefelfing (pta021/25.01.2019/14:38) - Dr. Hönle AG announces that the following financial reports shall be disclosed:

14.12.2018

Gräfelfing/München (pta005/14.12.2018/07:40) - According to preliminary figures, Hönle Group generated sales of TEur126,492 in the 2017/2018 financial year, which corresponds to an increase of 24.1% compared to the previous year. The operating result (EBIT) jumped by 101.8% to...

06.09.2018

Gräfelfing/München (pta033/06.09.2018/16:50) - Dr. Hönle AG, an innovative technology company located in Gräfelfing near Munich, will be included in the SDAX. Deutsche Börse has passed extensive rule changes for the indices DAX, MDAX, SDAX and TecDAX. As part of this new regulation...

10.08.2018

Gräfelfing/München (pta006/10.08.2018/08:10) - In the first nine months of financial year 2017/2018, the Hönle Group generated sales revenues of TEur88,750, representing a 23.2% increase year-on-year. The operating result (EBIT) jumped by 132.0% to TEur19,865 in the current financial...

13.06.2018

Graefelfing, Munich (pta031/13.06.2018/15:33) - Announcement

18.05.2018

Graefelfing/Munich (pta007/18.05.2018/07:30) - The Hönle Group's sales revenues increased by 28.5 % to TEur 60,671 in the first six months of the 2017/2018 financial year. The operating result surged by 167.6 % to TEur 15,047 due to the high proportion of adhesive revenues. Revenues...

28.03.2018

Gräfelfing/München (pta027/28.03.2018/21:00) - Release of Voting Rights Announcement

28.03.2018

Gräfelfing/München (pta028/28.03.2018/21:00) - Release of Voting Rights Announcement

28.03.2018

Gräfelfing/München (pta020/28.03.2018/14:00) - Release of Voting Rights Announcement

22.03.2018

Graefelfing, Munich (pta033/22.03.2018/18:49) - Release of Voting Rights Announcement

22.02.2018

Gräfelfing/München (pta010/22.02.2018/08:05) - In the first quarter of financial year 2017/2018, the Hönle Group generated revenues of TEur 29,535, which corresponds to a 33.2 % year-on-year increase. The operating result (EBIT) jumped by 231.8 % to TEur 7,392 in the current financial...

29.01.2018

Graefelfing, Munich (pta029/29.01.2018/14:08) - Dr. Hönle AG announces that the following financial reports shall be disclosed:

15.12.2017

Graefelfing, Munich (pta006/15.12.2017/08:05) - Preliminary figures indicate a 9.1 % rise in Hönle Group's revenues to TEur 101,926 in the financial year 2016/2017. The operating result (EBIT) improved by 22.6 % to TEur 15,207. Earnings before taxes climbed by 23.5 % to TEur 14,877 and...

21.11.2024

Gilching (pta014/21.11.2024/10:15) - The Management Board forecasted sales of around €100 million and a positive operating result (EBIT) for the Hönle Group for the 2023/24 financial year. Based on current knowledge, the Management Board assumes that the Hönle Group achieved a positive...

30.04.2024

Gilching (pta002/30.04.2024/00:40) - As communicated in the last capital market statement, the Management Board continues to assume that there will be an upturn in business activities in the second half of the financial year. However, the increase in sales and earnings will be weaker than...

09.02.2024

Gilching (pta007/09.02.2024/08:30) - The Hönle Group achieved lower sales and results in the first three months of the 2023/2024 financial year compared to the period of the previous year due to the weak market environment in machinery and plant engineering as well as order delays.

05.12.2023

Gilching (pta044/05.12.2023/20:00) - The Management Board expected for the Hönle Group, sales of €100 million to €105 million, an adjusted operating result (EBIT adjusted) of €5.5 million to €6.5 million and an operating result (EBIT ) between €7 million and €8 million in the...

20.10.2023

Gilching (pta022/20.10.2023/17:35) - The Supervisory Board of Dr. Hönle AG intends to appoint Dr. Markus Arendt as a member of the Management Board of Dr. Hönle AG with effect presumably from May 1st, 2024. He will follow Dr. Franz Richter, who was delegated to the Management Board by...

01.06.2023

Gilching (pta049/01.06.2023/21:45) - After change of the CEO/CFO the Management Board of Dr. Hönle AG has analysed intensively all segments and business areas of the Hönle Group in recent weeks.

25.04.2023

Gilching (pta044/25.04.2023/23:20) - The Supervisory Board of Dr. Hönle AG delegates Dr. Franz Richter, who currently holds the position of Chairman of the Supervisory Board of Dr. Hönle AG, as the successor to the Chairman of the Management Board, Mr. Norbert Haimerl, who is resigning...

20.02.2023

Gilching (pta038/20.02.2023/16:05) - According to preliminary figures, Hönle Group's sales revenues in the first three months of financial year 2022/2023 came to € 30.6 million and were thus 8.4% down from the previous year's level. Sales generated with air disinfection equipment, in...

21.12.2022

Gilching (pta033/21.12.2022/16:40) - According to preliminary figures, Hönle Group was able to increase its sales in the 2021/2022 financial year by 9.9% to € 126.5 million compared to the previous year.

12.12.2022

Gilching (pta024/12.12.2022/15:10) - As already announced on November 2, 2022, the Executive Board of Dr. Hönle AG decided to close the subsidiary Raesch Quarz (Germany) GmbH, Ilmenau, and to sell all the assets. Fortunately, an agreement has now been reached on the sale of the entire...

02.12.2022

Gilching (pta026/02.12.2022/15:35) - The corona pandemic led to massive demand for mobile air purification devices that were used to reduce the germ load and control the risk of infection. The use of mobile air cleaning devices in public education and training facilities was also...

02.11.2022

Gilching (pta016/02.11.2022/10:30) - The supervisory board of Dr. Hönle AG today approved the Management Board's proposal to initiate restructuring measures at the subsidiary Raesch Quartz (Germany) GmbH, Ilmenau, while safeguarding the rights of the bodies responsible for operational...

23.08.2022

Gilching (pta034/23.08.2022/16:30) - The supervisory board of Dr. Hönle AG has decided to fill the position of CEO, which was newly created in the course of the restructuring of the Management Board, with Management Board member Norbert Haimerl. Mr. Haimerl will assume the position of CEO...

29.07.2022

Gilching (pta042/29.07.2022/14:20) - Earnings in the third quarter were worse than planned. The situation on procurement markets and the increase in energy prices burden on quarterly earnings heavily. In addition, one-time effects affected the result. These are largely related to the...

22.07.2022

Gilching (pta028/22.07.2022/14:55) - Business development in the third quarter and especially in June 2022 was significantly worse than planned. The situation on procurement markets and the sharp increase in energy prices temporarily burden heavily on the Hönle Group's earnings. In...

18.02.2022

Gilching (pta012/18.02.2022/09:40) - The Management Board expects revenues of between € 130 and € 140 for the Hoenle Group and an operating result (EBIT) of between € 14 and € 17 million in financial year 2021/2022.

01.12.2021

Gilching (pta032/01.12.2021/14:55) - The Hönle Group benefited from the economic upturn and was able to significantly increase its sales and, above all, its incoming orders. In addition, the new group companies made a significant contribution to the expansion of business activities....

24.11.2021

Gilching (pta040/24.11.2021/18:30) - The assumptions made as part of the planning and now adjusted for the business development of a subsidiary of Dr. Hönle AG leads to non-cash impairment losses in the group in the fourth quarter. The impairments relate to goodwill in the amount of 3.4...

06.10.2021

Gilching (pta029/06.10.2021/17:20) - The move of the Dr. Hönle AG in the new company building resulted in less production and delivery than planned in the fourth quarter. In addition, long delivery times for electronic components, mechanical components and, in some cases, raw materials at...

15.07.2021

Gräfelfing/München (pta029/15.07.2021/14:40) - According to preliminary figures, Hönle Group sales revenues increased from Eur 71.7 million to Eur 84.9 million in the nine-month period. The operating result (EBIT) climbed from Eur 6.3 million to Eur 7.3 million. Adverse effects weighted...

15.09.2020

Gräfelfing/München (pta025/15.09.2020/14:00) - Dr. Hönle AG acquires 100% of the shares of UV-Technik Meyer GmbH based in Ortenberg (Hesse).

21.08.2020

Graefelfing, Munich (pta021/21.08.2020/12:55) - With Peter Möhrle Holding, the family office of the Peter Möhrle entrepreneur family, Dr. Hönle AG wins a new strategic investor for Hönle Group's growth financing.

17.08.2020

Gräfelfing/München (pta023/17.08.2020/12:50) - Dr. Hönle AG acquires STERILSYSTEMS GmbH. The Hönle Group is thus significantly expanding its activities in the life science sector. As a result of the pandemic, sensitivity to and global demand for disinfection solutions has risen...

27.04.2020

Graefelfing, Munich (pta021/27.04.2020/11:30) - The managing board of Dr. Hönle AG today decided to withdraw the outlook for the 2019/2020 financial year. The impact of the Covid-19 pandemic on the business development of the Hönle Group cannot be estimated currently.

04.12.2019

Gräfelfing, München (pta029/04.12.2019/15:10) - According to preliminary figures, the Hönle Group's revenue in the financial year 2018/2019 was TEur107,747, which is 14.8% below the previous year's figure. The operating result (EBIT) decreased from TEur30,687 to TEur17,003, which...

31.07.2019

Gräfelfing/München (pta042/31.07.2019/18:30) - The Management Board assumes that the Hönle Group will achieve sales of Eur 105 to 110 million and an operating result of Eur 17 to 19 million in the 2018/2019 financial year. Previously, the Management Board had assumed to achieve the...

26.04.2019

Gräfelfing/München (pta021/26.04.2019/10:50) - The Management Board expects the Hönle Group to reach the lower end of the previously communicated target corridor of Eur 115 to Eur 130 million in revenue and Eur 22 to Eur 30 million in operating profit in the 2018/2019 financial year.

09.11.2018

Gräfelfing/München (pta024/09.11.2018/12:16) - The Hönle Group again raises its forecast for financial year 2017/2018, expecting an operating result (EBIT) of between Eur 30.5 million and Eur 31.5 million instead of the initially projected Eur 26 to Eur 30 million. In financial year...

09.11.2018

Graefelfing, Munich (pta021/09.11.2018/11:20) - The Hönle Group again raises its forecast for financial year 2017/2018, expecting an operating result (EBIT) of between Eur 30.5 million and Eur 31.5 million instead of the initially projected Eur 26 to Eur 30 million. In financial year...

20.06.2018

Gräfelfing/München (pta030/20.06.2018/16:00) - The Hönle Group expects strong business development, especially in the adhesives segment, and therefore raises its forecast for the 2017/2018 financial year again. Instead of sales of between Eur 115 and 125 million, now sales of between...

04.12.2017

Gräfelfing/München (pta026/04.12.2017/15:30) - The Hönle Group increases its profit forecast (EBIT) for the financial year 2017/2018 from between Eur16 and 18 million to between Eur22 and 26 million. This considerable increase in profit is due to an anticipated strong development of the...

28.07.2016

Gräfelfing/Munich (pta022/28.07.2016/16:37) - The Hönle Group reduces its expectations for the current financial year. Revenues in the 2015/2016 financial year are expected to amount to Eur 90 to 92 million and the operating result will probably come to between Eur 12 and 13 million....

20.05.2015

Gräfelfing/München (pta025/20.05.2015/17:07) - The Dr. Hönle AG subsidiary, Panacol Elosol GmbH, concluded today a cooperation agreement with SKC Co. Ltd.. The agreement expresses the mutual will of both parties to establish a joint enterprise in Korea with a view to selling and...

09.12.2013

Graefelfing/Munich (pta019/09.12.2013/12:20) - According to preliminary figures, the Hönle Group earned revenues of Eur 77.3 million (PY: Eur 72.1 million) in the financial year 2012/2013. The operating result (EBIT) came to Eur 7.7 million (PY: Eur 8.3 million). As reported in the...

26.11.2013

Gräfelfing, Munich (pta023/26.11.2013/12:50) - A special effect resulting from accounting changes impacts positively on Hönle Group's financial result in the 2012/2013 financial year.